Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells

Blood

Volumn 89, Issue 9, 1997, Pages 3378-3384

  Bellosillo, Beatriz ^a,b   Dalmau, Mireia ^a,b   Colomer, Dolors ^a,b   Gil, Joan ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FLUDARABINE; INTERLEUKIN 4; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DIAGNOSIS; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

EID: 0030905543     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.9.3378     Document Type: Article

References (60)

1. Foon KA, Rai KR, Gale RP: Chronic lymphocytic leukemia: New insights into biology and therapy. Ann Intern Med 113:525, 1990
2. Gale RP, Caligaris-Cappio F, Dighiero G, Keating M, Montserrat E, Rai K: Recent progress in chronic lymphocytic leukemia. Leukemia 8:1610, 1994
3. Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM: Regulation of apoptosis in the immune system. Curr Opin Immunol 6:279, 1994
4. Wyllie AH, Kerr JF, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251, 1980
5. Mainou-Fowler T, Prentice AG: Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia. Leuk Lymphoma 21:369, 1996
6. Collins RJ, Verschuer LA, Harmon BV, Prentice RL, Pope JH, Kerr JFR: Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol 71:343, 1989
7. Dancescu M, Rubio-Trujillo M, B iron G, Bron D, Delespesse G, Sarfati M: Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 176:1319, 1992
8. Panayiotidis P, Ganeshaguru K, Jabbar SAB, Hoffbrand AV: Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br J Haematol 85:439, 1993
9. Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK: Interferon y inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 177:213, 1993
10. Panayiotidis P, Ganeshaguru K, Jabbar SAB, Hoffbrand AV: Alpha-interferon (or-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro. Br J Haematol 86:169, 1994
11. Huang RW, Tsuda H, Takatsuki K: Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells. Int J Hematol 58:83, 1993
12. Reittie JE, Yong KL, Panayiotidis P, Hoffbrand AV: Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia. Leuk Lymphoma 22:83, 1996
13. Francia di Celle P, Mariani S, Riera L, Stacchini A, Reato G, Foa R: Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 87:4382, 1996
14. Chaouchi N, Wallon C, Goujard C, Tertian G, Rudent A, Caput D, Ferrera D, Minty A, Vazquez A, Delfraissy JF: Interleukin13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood 87:1022, 1996
15. Fluckiger AC, Durand I, BanchereauJ: Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J. Exp Med 179:91, 1994
16. Mainou-Fowler T, Craig VA, Copplestone A, Hamon MD, Prentice AG: Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression, and is inhibited by IL-4. Blood 84:2297, 1994
17. McConkey DJ, Aguilar-Santelises M, Hartzell P, Eriksson I, Mellstedt H, Orrenius S, Jondal M: Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. J Immunol 146:1072, 1991
18. Carrera CJ, Piro LD, Saven A, Beutler E, Terai C, Carson DA: 2ChIorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes. Adv Exp Med Biol 309A:15, 1991
19. Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN, Plunkett W: Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-/3-Darabinosyl-2-fluoroadenine. Blood 81:143, 1993
20. Begleiter A, Lee K, Israels LG, Mowat MRA, Johnston JB: Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy. Leukemia 8:S103, 1994 (suppl 1)
21. Zinzani PL, Buzzi M, Farabegoli P, Tosi P, Fortuna A, Visani G, Martinelli G, Zaccaria A, Tura S: Induction of "in vitro" apoptosis by fludarabine in freshly isolated B-chronic lymphocytic leukemia cells. Leuk Lymphoma 13:95, 1994
22. Reed JC: Bcl-2 and the regulation of programmed cell death. JCell Biol 124-1, 1994
23. Schena M, Larsson LG, Gottardi D, Gaidano G, Carlsson M, Nilsson K, Caligaris-Cappio F: Growth- and differentiation-associ-
24. ated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 79:2981, 1992
25. Mariano MT, Moretti L, Donelli A, Grantini M, Montagnani G, Di Frisco AU, Torelli G, Torelli U, Nami F: bcl-2 gene expression in hematopoietic cell differentiation. Blood 80:768, 1992
26. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC: bcl2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820, 1993
27. Cory S: Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 13:513, 1995
28. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88:386, 1996
29. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241, 1993
30. Kane DJ, Sarafian TA, Anton R, Hahn H, Butler Gralla E, Seiverstone Valentine J, Örd T, Bredesen DE: Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 262:1274, 1993
31. Lam M, Dubyak G, Chen L, Nunez G, Miesfeld RL, Distelhorst CW: Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc Natl Acad Sei USA 91:6569, 1994
32. Martin SJ, Green DR: Protease activation during apoptosis: Death by a thousand cuts? Cell 82:349, 1995
33. Chinnaiyan AM, Dixit VM: The cell-death machine. Curr Biol 6:555, 1996
34. Henkart PA: ICE family of proteases: Mediators of all apoptotic cell death? Immunity 4:195, 1996
35. De Murcia G, Ménissier de Murcia J: PoIy(ADP-ribose) polymerase: A molecular nick-sensor. Trends Biochem Sei 19:172, 1994
36. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976, 1993
37. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346, 1994
38. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM: Yama/CPP32/3, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801, 1995
39. Nicholson D\V, Ali A, Thombeny NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
40. An S, Knox KA: Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptortriggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP. FEES Lett 386:115, 1996
41. Binet JL, Leporria M, Dighiero G, Charron P, D'Athis P, Vaugier G, Merle-Beral H, Natali JC, Raphaël M, Nizet B, Follezou JY: A clinical staging system for chronic lymphocytic leukemia. Cancer 40:855, 1977
42. Carballo E, Colomer D, Vives Corrons JL, Blackshear PJ, Gil J: Characterization and purification of a protein kinase C substrate in human B cells. J Immunol 156:1709, 1996
43. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55, 1983
44. Forbes IJ, Zalewski PD, Giannakis C, Cowled PA: Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp Cell Res 198:367, 1992
45. Laemmli UK:Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
46. Ascaso R, Marvel J, Collins MKL, Lopez-Rivas A: Interleukin-3 and Bcl-2 cooperatively inhibit etoposide-induced apoptosis in a murine pre-B cell line. Eur J Immunol 24:537, 1994
47. Montserrat E, Rozman C: Chronic lymphocytic leukemia: Present status. Ann Oncol 6:219, 1995
48. Dolle RE, Singh J, Rinker J, Hoyer D, Prasad CV, Graybill TL, Salvino JM, Helaszek CT, Miller, RE, Ator MA: Aspartyl alpha((1-phenyl-3-(trifluoromethyl)-pyrazol-5-yl)oxy)methyl ketones as interleukin-1 beta converting enzyme inhibitors. Significance of the PI and P3 amido nitrogens for enzyme-peptide inhibitor binding. J Med Chem 37:3863, 1994
49. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803, 1996
50. Muzio M, Chinnaiyan AM, Kischkel EC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADDhomologous ICE/CED-3/-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817, 1996
51. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG, Dixit VM: Molecular ordering of the cell death pathway. J Biol Chem 271:4573, 1996
52. Boulakia CA, Chen G, Ng FWH, Teodoro JG, Branton PE, Nicholson DW, Poirier GG, Shore GC: Bcl-2 and adenovirus E1B 19 kDa protein prevent El A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene 12:529, 1996
53. Monney L, Otter I, Olivier R, Ravn U, Mirzasaleh H, Fellay I, Poirier GG, Borner C:- BcI-2 overexpression blocks activation of the death protease CPP32/Yama/Apopain. Biochem Biophys Res Commun 221:340, 1996
54. Wang ZQ, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M, Wagner EF: Mice lacking ADPRT and poly(ADPribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 9:509, 1995
55. Schreiber V, Hunting D, Trucco C, Gowans B, Grunwald D, de Murcia G, Menissier de Murcia J: A dominant-negative mutant of human poly(ADP-ribose) polymerase affects cell recovery, apoptosis, and sister chromatid exchange following DNA damage. Proc Natl Acad Sei USA 92:4753, 1995
56. Bramson J, Prévost J, Malapetsa PA, Noë AJ, Poirier GG, DesNoyers S, Alaoui-Jamali M, Panasci L: Poly(ADP-ribose) polymerase can bind melphalan damaged DNA. Cancer Res 53:5370, 1993
57. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thomberry NA, Miller DK, Rosen A: Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death. J Exp Med 183:1957, 1996
58. Fernandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L, Tomaselli KJ, Wang L, Yu Z, Croce CM, Salveson G, Earnshaw WC, Litwack G, Alnemri ES: Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 55:6045, 1995
59. Femandes-Alnemri T, Litwack G, Alnemri ES: Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res 55:2737, 1995
60. Fernandes-Alnemri T, Litwack G, Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1/Öconverting enzyme. J Biol Chem 269:30761, 1994